A joint resolution providing for congressional disapproval under chapter 8 of…

This joint resolution invokes the Congressional Review Act (CRA) of 1996, which gives Congress a fast-track mechanism to overturn federal agency rules within a window following their submission to Congress. The target rule, issued by the Centers for Medicare and Medicaid Services (CMS), sets the Notice of Benefit and Payment Parameters for 2027. These annual rules are among the most consequential regulatory actions affecting the individual health insurance market, as they determine premium calculation methodologies, insurer payment adjustments (risk adjustment), cost-sharing structures, and eligibility and payment rules for the Basic Health Program (BHP) administered by states like New York and Minnesota. The constitutional basis for this resolution rests on Article I authority over federal spending and regulation, combined with the statutory framework of the CRA. Congress contends that major regulatory decisions of this scope, affecting hundreds of billions of dollars in federal subsidies and the coverage of tens of millions of Americans, warrant direct legislative oversight rather than delegation to executive agencies. Supporters argue this is a legitimate check on administrative power, particularly as questions about the scope of agency authority have grown following Supreme Court decisions limiting regulatory overreach. The fiscal implications are substantial. The ACA marketplace serves roughly 21 million enrollees as of recent years, and the 2027 payment parameters directly govern how billions in premium tax credits and cost-sharing reductions are calculated and distributed. The Basic Health Program serves approximately 1 million low-income adults in participating states. Nullifying this rule could create regulatory uncertainty for insurers, states, and enrollees heading into a plan year, potentially disrupting premium setting and enrollment cycles. Historically, CRA resolutions targeting ACA-related rules have been used by both parties to challenge agency actions they oppose. The Obama, Trump, and Biden administrations all faced CRA challenges to various regulatory actions. Successfully passing a CRA resolution requires simple majorities in both chambers and either a presidential signature or a veto override. This resolution reflects ongoing congressional tension over the scope of executive agency authority to shape the health insurance market under the ACA framework. Stakeholders affected include individual market health insurers, state insurance commissioners, ACA marketplace enrollees, Basic Health Program participants (primarily in New York and Minnesota), navigators and enrollment assisters, and federal and state budget offices that rely on the rule for financial planning.

AI analysis of the official record. Sage explains the record and never tells you how to vote.

Congress is considering a resolution that would cancel a federal rule governing how health insurance premiums, subsidies, and benefits are calculated for 2027 under the Affordable Care Act. The rule, issued by the Centers for Medicare and Medicaid Services, is the kind of annual regulatory update that sets the financial and structural parameters for the individual insurance market and the Basic Health Program, a coverage option for low-income adults in states like New York and Minnesota. The resolution uses the Congressional Review Act, a 1996 law that allows Congress to nullify agency rules by passing a joint resolution of disapproval. Supporters of the resolution argue that rules of this magnitude, affecting coverage for more than 21 million marketplace enrollees and hundreds of billions in federal subsidies, should require direct congressional approval rather than being left to agency discretion. They contend the rule contains provisions that go beyond what the ACA authorizes and that accountability demands elected representatives take ownership of major health policy decisions. Some supporters also cite broader concerns about executive agency overreach following recent Supreme Court rulings that have curtailed regulatory authority. Opponents warn that canceling the rule this close to the 2027 plan year would inject serious uncertainty into the insurance market. Insurers rely on these parameters to set premiums, design plans, and submit bids. State governments and Basic Health Program administrators would face operational and funding gaps without a governing regulatory framework. Critics argue the Congressional Review Act is too blunt a tool for technical, actuarially complex rules that require expert management, and that using it here risks real harm to low-income enrollees who depend on program stability. For ordinary Americans, the practical stakes depend on whether Congress acts and what replaces the nullified rule. Marketplace enrollees could see disruptions to premium calculations or plan availability if insurers and states cannot plan around a stable regulatory baseline. Basic Health Program participants in eligible states face the most direct exposure, as payment parameters govern their coverage funding. The resolution has been placed on the Senate calendar, meaning it could come to a floor vote, but its ultimate fate depends on whether it clears both chambers and survives any presidential response.